Rankings
▼
Calendar
VCYT FY 2025 Earnings — Veracyte, Inc. Revenue & Financial Results | Market Cap Arena
VCYT
Veracyte, Inc.
$3B
FY 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$517M
+16.0% YoY
Gross Profit
$360M
69.6% margin
Operating Income
$74M
14.3% margin
Net Income
$66M
12.8% margin
EPS (Diluted)
$0.82
Cash Flow
Operating Cash Flow
$136M
Free Cash Flow
$127M
Stock-Based Comp.
$44M
Balance Sheet
Total Assets
$1.4B
Total Liabilities
$96M
Stockholders' Equity
$1.3B
Cash & Equivalents
$363M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$517M
$446M
+16.0%
Gross Profit
$360M
$298M
+20.8%
Operating Income
$74M
$16M
+359.4%
Net Income
$66M
$24M
+174.9%
← Q4 2024
All Quarters
Q1 2025 →